AU2001280035A1 - Intracellular delivery system for protein phosphatases and other polypeptides - Google Patents

Intracellular delivery system for protein phosphatases and other polypeptides

Info

Publication number
AU2001280035A1
AU2001280035A1 AU2001280035A AU8003501A AU2001280035A1 AU 2001280035 A1 AU2001280035 A1 AU 2001280035A1 AU 2001280035 A AU2001280035 A AU 2001280035A AU 8003501 A AU8003501 A AU 8003501A AU 2001280035 A1 AU2001280035 A1 AU 2001280035A1
Authority
AU
Australia
Prior art keywords
polypeptides
delivery system
intracellular delivery
protein phosphatases
phosphatases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001280035A
Inventor
Sara Lavi
Ronit Satchi-Fainaro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ramot at Tel Aviv University Ltd
Original Assignee
Ramot at Tel Aviv University Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ramot at Tel Aviv University Ltd filed Critical Ramot at Tel Aviv University Ltd
Publication of AU2001280035A1 publication Critical patent/AU2001280035A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001280035A 2000-07-26 2001-07-26 Intracellular delivery system for protein phosphatases and other polypeptides Abandoned AU2001280035A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US22097100P 2000-07-26 2000-07-26
US60220971 2000-07-26
US66871300A 2000-09-22 2000-09-22
US09668713 2000-09-22
PCT/IL2001/000689 WO2002007671A2 (en) 2000-07-26 2001-07-26 Intracellular delivery system for protein phosphatases and other polypeptides

Publications (1)

Publication Number Publication Date
AU2001280035A1 true AU2001280035A1 (en) 2002-02-05

Family

ID=26915374

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001280035A Abandoned AU2001280035A1 (en) 2000-07-26 2001-07-26 Intracellular delivery system for protein phosphatases and other polypeptides

Country Status (3)

Country Link
US (1) US20040067527A1 (en)
AU (1) AU2001280035A1 (en)
WO (1) WO2002007671A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001282427A1 (en) * 2000-07-26 2002-02-05 Ramot University Authority For Applied Research And Industrial Development Ltd. Intracellular delivery system for protein phosphatases
US7723296B2 (en) 2001-01-18 2010-05-25 Genzyme Corporation Methods for introducing mannose-6-phosphate and other oligosaccharides onto glycoproteins and its application thereof
PL1877099T3 (en) 2005-04-06 2013-02-28 Genzyme Corp Therapeutic conjugates comprising a lysosomal enzyme, polysialic acid and a targeting moiety
WO2008089403A2 (en) 2007-01-18 2008-07-24 Genzyme Corporation Oligosaccharides comprising an aminooxy group and conjugates thereof
CN105879047A (en) 2008-12-16 2016-08-24 建新公司 Oligosaccharide-protein conjugates
EP2353858A1 (en) 2010-02-09 2011-08-10 Boegli-Gravures S.A. Device for embossing wrapping films
EP2399732A1 (en) 2010-06-22 2011-12-28 Boegli-Gravures S.A. Device for embossing films
EP2511088A1 (en) 2011-04-12 2012-10-17 Boegli-Gravures S.A. Method and device for producing a package for tobacco articles
US20140213775A1 (en) 2011-09-14 2014-07-31 Abeterno Limited Intracellular cell selection
GB201306589D0 (en) 2013-04-11 2013-05-29 Abeterno Ltd Live cell imaging

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5548064A (en) * 1993-05-24 1996-08-20 Biotech Australia Pty Limited Vitamin B12 conjugates with EPO, analogues thereof and pharmaceutical compositions
US5951974A (en) * 1993-11-10 1999-09-14 Enzon, Inc. Interferon polymer conjugates

Also Published As

Publication number Publication date
WO2002007671A2 (en) 2002-01-31
WO2002007671A3 (en) 2002-04-25
US20040067527A1 (en) 2004-04-08

Similar Documents

Publication Publication Date Title
AU2484399A (en) Controlled release delivery of peptide or protein
AU2001288388A1 (en) Substance delivery system
AU2001276737A1 (en) Protein injection preparations
AU6906800A (en) Membrane associated proteins
AU6058500A (en) Fusion protein and uses thereof
AU2001268459A1 (en) Secure test and test result delivery system
AU2001291049A1 (en) Defensin-antigen fusion proteins
AU2001264789A1 (en) Protein powder for pulmonary delivery
AU6045900A (en) Interaction-activated proteins
AU7829700A (en) Protein phosphatase and kinase proteins
AU6232300A (en) Receptors and associated proteins
AU2001280035A1 (en) Intracellular delivery system for protein phosphatases and other polypeptides
AU1608201A (en) Human zven proteins
AU2002232803A1 (en) Expression system for recombinant proteins
AU5778400A (en) Prion protein binding proteins and uses thereof
AU2001269888A1 (en) Protein phosphatases
AU2420997A (en) Oligopeptides for drug delivery
AU7508100A (en) Human seizure related proteins
AU3768199A (en) Human protease associated proteins
AU2136401A (en) P450rai-2 and related proteins
AU2001213286A1 (en) Multi-valve delivery system
AU2001274676A1 (en) Plant-signalling ligand like proteins
AU2002239747A1 (en) Cystoskeleton-associated proteins
AU2001244863A1 (en) Apoptin-associating protein
AU2001282427A1 (en) Intracellular delivery system for protein phosphatases